search icon
      blog search icon

      It’s Strange How Optec International, Inc. (OTC: OPTI)’s Share Price Moves Ahead of the Fundamentals - Stocks Telegraph

      By Hasnain R

      Published on

      February 18, 2021

      1:25 PM UTC

      It’s Strange How Optec International, Inc. (OTC: OPTI)’s Share Price Moves Ahead of the Fundamentals - Stocks Telegraph

      On Wednesday, OPTEC International, Inc. (OTC PINK: OPTI) closed at $0.3422, up 11.03%, and has been trading in a range of $0.3847 and $0.2750. Over the last month, OPTI shares surged over 214.52%, with a month-over-month volume of 43.79M shares.

      OPTI operational details

      OPTEC International, Inc. (OTC PINK: OPTI) has offices in Carlsbad and Vista, California, and develops and manufactures electronic LED, UV & UVC safety products, and other Advanced Technology and Personal Protection Equipment.

      Recent Developments

      OPTEC International, Inc. (OTC PINK: OPTI) generated a revenue increase of over 1000% over the previous quarter in its Quarterly Financial Report for the period ending December 31, 2020. In response to the significant rise in Pandemic cases globally, intense and larger transaction volumes were achieved.

      This period saw an increase in revenue over $11 million, which resulted in a net income of about $7 million, increasing shareholder equity to $17 million.

      According to the company CEO Roger Pawson, its continued growth has acquired a 17,298 sq. foot warehouse and distribution center next to its existing facilities. Employees of the company will assume possession of the new facility on March 1, 2021.

      Before that, OPTEC has added Antigen & Antibody Rapid-Test Kits for global distribution to the company’s PPE Inventory. Throughout the United States, Rapid-Test Kits are manufactured to meet Rapid-Testing requirements under the current FDA and CDC guidelines.

      Moreover, Former CDC Chief of Staff Kyle McGowan and Amanda Campbell are named the OPTEC Advisory Board.

      Summary:

      Investors are thinking about how much they can allocate to U.S. technology stocks in the coming year, as pricier valuations, regulatory risks, and the return of the beaten-down names to the market threaten their allures.

      More From Stocks telegraph